Today's Chart of the Day is Novo Nordisk (NVO). The stock was found on Barchart's New High list which we then sorted for frequency over the past 3 months. The Company is a leader in the development and production of Diabetes treating drugs and it's once a day Type 2 Diabetes drug Victoza has been a block buster. The Trend spotter first gave a buy signal on 12/28 at 162.26 and since then the stock has enjoyed 28 new highs.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 100% Barchart technical buy signals
- Trend Spotter buy signals
- Above its 20, 50 and 100 day moving averages
- 28 new highs and up 20.49% in the last 3 months
- Eelative Strength Index 80.13
- Barchart computes a technical support level at 187.08
- Recently traded at 190.59 with a 50 day moving average of 167.57
Fundamental factors:
- Market Cap $110.54 billion
- P/E 27.11
- Dividend yield .99%
- Analysts project revenue to increase by 8.90% this year and another 14.90% next year
- Earnings are estimated to grow by 20.70% this year, 20.70% next year and continue to increase annually by 17.95% for the next 5 years
- Analysts released 2 strong buy, 2 hold and 1 strong sell recommendations to their clients
- The project investors at this level might see an annual total return in the 8.50% range over the next 5 years
- Financial Strength is A++
No comments:
Post a Comment